Parallel Advisors LLC Raises Stock Position in Healthpeak Properties, Inc. $DOC

Parallel Advisors LLC increased its stake in Healthpeak Properties, Inc. (NYSE:DOC) by 8.7% in the 2nd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 15,195 shares of the real estate investment trust’s stock after acquiring an additional 1,215 shares during the quarter. Parallel Advisors LLC’s holdings in Healthpeak Properties were worth $266,000 at the end of the most recent reporting period.

A number of other large investors have also modified their holdings of DOC. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its holdings in shares of Healthpeak Properties by 584.6% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 9,218,848 shares of the real estate investment trust’s stock worth $186,405,000 after buying an additional 7,872,150 shares in the last quarter. Nuveen LLC purchased a new stake in shares of Healthpeak Properties in the first quarter valued at about $124,113,000. Invesco Ltd. grew its holdings in shares of Healthpeak Properties by 20.7% in the first quarter. Invesco Ltd. now owns 23,111,320 shares of the real estate investment trust’s stock valued at $467,311,000 after purchasing an additional 3,967,830 shares during the period. Goldman Sachs Group Inc. grew its holdings in shares of Healthpeak Properties by 57.8% in the first quarter. Goldman Sachs Group Inc. now owns 6,764,854 shares of the real estate investment trust’s stock valued at $136,785,000 after purchasing an additional 2,477,307 shares during the period. Finally, Amundi grew its holdings in shares of Healthpeak Properties by 89.4% in the first quarter. Amundi now owns 5,047,699 shares of the real estate investment trust’s stock valued at $98,228,000 after purchasing an additional 2,382,657 shares during the period. Hedge funds and other institutional investors own 93.57% of the company’s stock.

Healthpeak Properties Stock Performance

Shares of DOC opened at $18.48 on Monday. The company has a current ratio of 1.28, a quick ratio of 1.28 and a debt-to-equity ratio of 1.06. The firm has a market cap of $12.84 billion, a PE ratio of 77.00, a price-to-earnings-growth ratio of 2.38 and a beta of 1.07. The company’s 50 day simple moving average is $17.76 and its 200-day simple moving average is $18.10. Healthpeak Properties, Inc. has a 12-month low of $16.63 and a 12-month high of $23.26.

Healthpeak Properties (NYSE:DOC) last announced its earnings results on Thursday, July 24th. The real estate investment trust reported $0.46 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.46. The business had revenue of $694.35 million for the quarter, compared to analyst estimates of $697.14 million. Healthpeak Properties had a net margin of 5.90% and a return on equity of 1.85%. The company’s revenue for the quarter was down .2% compared to the same quarter last year. During the same period last year, the firm posted $0.45 earnings per share. Healthpeak Properties has set its FY 2025 guidance at 1.810-1.870 EPS. As a group, equities analysts predict that Healthpeak Properties, Inc. will post 1.86 EPS for the current year.

Healthpeak Properties Dividend Announcement

The firm also recently announced a monthly dividend, which was paid on Friday, August 29th. Stockholders of record on Monday, August 18th were given a dividend of $0.1017 per share. The ex-dividend date was Monday, August 18th. This represents a c) dividend on an annualized basis and a dividend yield of 6.6%. Healthpeak Properties’s dividend payout ratio (DPR) is 508.33%.

Insider Activity

In related news, CEO Scott M. Brinker purchased 2,930 shares of the firm’s stock in a transaction that occurred on Thursday, July 31st. The stock was purchased at an average cost of $17.06 per share, with a total value of $49,985.80. Following the completion of the acquisition, the chief executive officer directly owned 210,416 shares in the company, valued at $3,589,696.96. This trade represents a 1.41% increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is accessible through this link. Insiders have purchased 8,783 shares of company stock worth $150,129 in the last 90 days. Company insiders own 0.23% of the company’s stock.

Wall Street Analysts Forecast Growth

DOC has been the subject of a number of analyst reports. Robert W. Baird set a $21.00 price objective on shares of Healthpeak Properties and gave the company an “outperform” rating in a report on Wednesday, July 30th. Wells Fargo & Company decreased their target price on shares of Healthpeak Properties from $20.00 to $18.00 and set an “equal weight” rating on the stock in a research report on Wednesday, August 27th. Raymond James Financial raised shares of Healthpeak Properties from a “market perform” rating to an “outperform” rating and set a $20.00 price target on the stock in a research report on Monday, September 15th. Deutsche Bank Aktiengesellschaft reissued a “hold” rating and set a $18.00 price target (down previously from $28.00) on shares of Healthpeak Properties in a research report on Wednesday, August 20th. Finally, Wall Street Zen cut shares of Healthpeak Properties from a “hold” rating to a “sell” rating in a research report on Monday, July 7th. Eight analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. According to MarketBeat, Healthpeak Properties presently has an average rating of “Moderate Buy” and a consensus price target of $21.45.

Healthpeak Properties Profile

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.